Abstract: A subcutaneously implantable device includes a housing, a clip attached to the housing, a prong, and an electrode. The clip is configured to anchor the device to a muscle, a bone, and/or a first tissue. The prong has a base portion attached to the housing, an arm portion extending from the base portion so as to define a first plane that includes opposite ends of the arm portion of the prong and is perpendicular to a horizontal plane of the housing, and a contact portion that is configured to contact an organ, a nerve, the first tissue, and/or a second tissue. The contact portion is angled away from the first plane. The electrode is at the contact portion of the prong. The electrode is configured to contact the organ, the nerve, the first tissue, and/or a second tissue. Circuitry in the housing is in electrical communication with the electrode and is configured to provide monitoring, therapeutic, and/or diagnostic capabilities with respect to the organ, the nerve, the first tissue, and/or the second tissue.

Abstract: According to one embodiment, an X-ray diagnostic system is used with an operation apparatus for operating, from a position separated from an object, a device inserted inside the object, and includes an imaging apparatus, an designation receiving circuit, a first display, and a second display. The imaging apparatus performs X-ray imaging of the object. The designation receiving circuit receives designation of a position on medical data from a first user who operates the device. The first display is disposed at a position visible from the first user, and displays a first image according to the designation of the position. The second display is disposed at a position visible from a second user who performs positioning of the imaging apparatus, and displays a second image different from the first image according to the designation of the position.

Abstract: An integrated circuit includes: a radio-frequency (RF) to direct current (DC) rectifying circuit coupled to one or more antenna on an implantable wirelessly powered device, the rectifying circuit configured to: rectify an input RF signal received at the one or more antennas and from an external controller through electric radiative coupling; and extract DC electric power and configuration data from the input RF signal; a logic control circuit connected to the rectifying circuit and a driving circuit, the logic control circuit configured to: generate a current for the driving circuit solely using the extracted DC electrical power; in accordance with the extracted configuration data, set polarity state information for each electrode; and a driving circuit coupled to one or more electrode, the driving circuit comprising current mirrors and being configured to: steer, to each electrode and via the current mirrors, a stimulating current solely from the generated current.

Abstract: A method for treating episodes of apnoea and/or hypopnea is provided. The method has the steps of: a) detecting or predicting an episode of apnoea and/or hypopnea by means of at least one sensor selected from a respiratory pressure sensor, a pulse oximeter, an acoustic sensor and/or a respiratory temperature sensor; and b) emitting an electrical signal by means of an electrical actuator connected to at least one submental nerve and/or muscle, the electrical signal having a bipolar waveform and a frequency between 5 and 100 Hz.

Abstract: The present invention relates to methods and systems for planning and/or providing neuromodulation. An example system comprises a neurostimulator comprising a least one electrode, functional mapping module configured and arranged such that based on stimulation related basic data and stimulation related response data and transfer data a digital characteristic functional map is generated and/or provided, which describes the interrelation between the stimulation related basic data and the stimulation related response data and the transfer data, and analysis module configured and arranged such that the digital characteristic functional map may be analyzed in connection with neurostimulation provided by the neurostimulator such that the provided neurostimulation and its response may be analyzed on the basis of the functional map and that on the basis of this analysis a placement analysis of a placement of the electrode is provided.

Abstract: The present disclosure relates to a neuromodulation and/or neurostimulation system comprising at least the following components: at least one sensing unit, at least control unit, at least one stimulation unit, at least one Central Nervous System (CNS) stimulation module, at least one Peripheral Nervous System (PNS) stimulation module, wherein at least one of the components of the neuromodulation and/or neurostimulation system is implantable.

Abstract: An introducing device for locating a tissue region and deploying an electrode is shown and described. The introducing device may include an outer sheath. An inner sheath may be disposed within the outer sheath. The inner sheath may be configured to engage an implantable electrode. In an example, the inner sheath may comprise a stimulation probe having an uninsulated portion at or near a distal end of the delivery sheath. The outer sheath may be coupled to a power source or stimulation signal generating circuitry at a proximal end. A clinician may control application of the stimulation signal to a tissue region via the outer sheath.

Abstract: The present disclosure relates to systems and methods for analyzing physiological sign information, including information acquisition, data storage, calculation or analysis, processing, result output, etc. The systems may perform a calculation or an analysis on the acquired information by a plurality of algorithms, perform a determination or a processing on the calculation result, and output the determination result of the processed physiological information.

Abstract: A system (400) for monitoring an individual's sleep includes: (i) a patient monitor (410) configured to obtain a patient waveform, the patient waveform comprising information representative of a vital statistic of the patient; a processor (420) in communication with the patient monitor and configured to: (i) process the patient waveform to generate a segmented waveform; (ii) extract at least one feature from a segment of the waveform in a time domain and/or at least one feature from the segment of the waveform in the frequency domain; (iii) classify, using the at least one extracted feature, a sleep stage of the patient for the segment of the waveform; and (iv) generate, from classified sleep stages for a plurality of segments of the waveform, a sleep quality measurement; and a user interface (480) configured to report the generated sleep quality measurement.

Abstract: Disclosed are systems and methods for the treatment of cardiac arrhythmias.

Abstract: Neuromodulation electrodes and related methods to treat pelvic floor disorders, such as urinary and/or faecal incontinence, using electrical stimulation of the left and/or right branches of the dorsal genital nerves, or pudendal nerve, using a highly flexible electrode unit to obtain stable and comfortable contact with the cutaneous tissue or mucous membrane at or near the glans of the clitoris, in close proximity of the targeted nerve, for stabile neuromodulation applications.

Abstract: A method of treating hypertension in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a tissue location associated with the hypertension. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.

Abstract: Described herein is a method for identifying a farm animal having an impairment of regulative capacity in response to metabolic stress, the method including: a) assessing the value of the nonlinear domain heart rate variability component LMAX of a farm animal based on a heart beat interval data set obtained for the farm animal; and b) comparing the value of LMAX assessed according to (a) with a species specific threshold of LMAX, whereby a farm animal having an impairment of regulative capacity will be identified.

Abstract: A neuromodulation catheter is positionable in a blood vessel having a wall for use in delivering therapeutic energy to targets external to the blood vessel. An electrically insulative substrate such as an elongate finger is carried at a distal end of the catheter body. The substrate has a first face carrying a plurality of electrodes, and a second face on an opposite side of the substrate from the first face. The finger is biased such that when expanded within the blood vessel, it forms a spiral configuration with the first face facing outwardly to bias the electrodes in contact with the blood vessel wall.

Abstract: An ablation instrument (e.g., an ablation balloon catheter system) includes an elongate catheter having a housing with a window formed therein. An energy emitter is coupled to the elongate catheter and is configured to deliver ablative energy. A controller is received within the window and is coupled to the energy emitter such that axial movement of the controller within the window is translated to axial movement of the energy emitter and rotation of the controller within the window is translated into rotation of the energy emitter. The instrument includes a motor that is at least partially disposed within the housing of the catheter; a first gear that is operatively connected to and driven by the motor; and a second gear that is coupled to the energy emitter and is driven by the first gear to cause rotation of the energy emitter, while allowing the energy emitter to move axially.

Abstract: The present invention involves methods and systems for treatment of brain disorders using neuromodulation of brain networks. Implantation occurs by selecting sites which modulate the network in selected manners, or are modulated by a stimulus in a particular manner that is relevant to treatment of the network. The candidate locations within a brain region are evaluated in relation to how these are indirectly modulated by stimulation at a different brain region. Treatment of one or more brain networks associated with a brain disorder is realized with a consideration of network dynamics and coupling effects such as indirect stimulation of non-target regions. A brain modulation system (BMS) increases, decreases, or otherwise modulates network regional activity in a differential manner. Therapy and electrode locations are adjusted using sensed data and target implantation criteria related to the brain network model.

Abstract: The present invention is a system for detecting, tracking and recognizing human faces in a visual prosthesis. In a visual prosthesis, the input camera is always higher resolution than the electrode array providing percepts to the subject. It is advantageous to detect, track and recognize human faces. This information can be provided to the subject by highlighting the face in the visual scene, providing auditor or vibratory notice that a human face is in the visual scene, looking up the face in a database to identify and annunciate the name of the person in the visual scene, or otherwise communicate the identity of the person, like providing a custom vibratory pattern corresponding to known individuals (like custom ring tones associated with caller ID) or automatically zooming in on a face to aid the subject in identifying the face.

Abstract: The present application discloses a method for identifying arrhythmia, a device for identifying arrhythmia, and a computer readable medium. The method includes: acquiring a type of arrhythmia to be identified; acquiring an ECG signal collected by an ECG acquisition device; detecting feature wave information in the ECG signal according to the type of arrhythmia to be identified; extracting a feature parameter from the denoised ECG signal and the feature wave information according to the type of arrhythmia to be identified; and identifying, by a classifier, an occurrence of the type of arrhythmia to be identified according to the feature parameter.

Abstract: Methods, devices and program products are provided for under control of one or more processors within an implantable medical device (IMD). Sensing near field (NF) and far field (FF) signals are between first and second combinations of electrodes coupled to the IMD. The method applies an arrhythmia detection algorithm to the NF signals for identifying events within the NF signal and designates events marker based thereon and monitors the event markers to detect a candidate arrhythmia condition in the NF signals. The candidate under-detected condition comprises at least one of an under-detected arrhythmia or over-sensing. In response to detection of the candidate arrhythmia condition, the method analyzes the FF signals for a presence of an under-detected arrhythmia indicator. The method delivers an arrhythmia therapy based on the presence of the under-detected arrhythmia indicator in the FF signals and the candidate under-detected arrhythmia condition in the NF signals.

Abstract: A personal monitoring device has a sensor assembly configured to sense physiological signals upon contact with a user's skin. The sensor assembly produces electrical signals representing the sensed physiological signals. A converter assembly, integrated with, and electrically connected to the sensor assembly, converts the electrical signals generated by the sensor assembly to a frequency modulated physiological audio signal having a carrier frequency in the range of from about 6 kHz to about 20 kHz.